Engineering living cells to produce cannabinoid building blocks sustainably

This groundbreaking study demonstrates a sustainable biotechnology approach to producing olivetolic acid (OLA), a critical building block for cannabinoid synthesis. Rather than relying on resource-intensive plant extraction or complex chemical processes, researchers genetically engineered a photosynthetic cyanobacterium (Synechocystis sp. PCC 6803) to produce OLA through metabolic engineering. By introducing three key plant enzymes—tetraketide synthase, olivetolic acid cyclase, and acyl-activating enzyme 1—the research team successfully created a living biofactory capable of synthesizing this essential cannabinoid precursor using light and simple nutrients.

The breakthrough came through clever optimization strategies that focused on removing metabolic bottlenecks. Researchers discovered that disrupting the glycogen storage pathway and boosting malic enzyme production significantly increased OLA yield in their engineered cells. However, the study revealed an important trade-off: while increased CO₂ and aeration boosted cell growth, it paradoxically reduced the amount of OLA produced per cell. This finding highlights the complex balance required in metabolic engineering between rapid biomass expansion and target molecule production.

The implications are substantial for the cannabis industry and environmental sustainability. This cyanobacterial platform offers a renewable, sun-powered alternative to traditional extraction and synthesis methods, potentially reducing resource consumption, chemical waste, and manufacturing costs. The work establishes a foundational blueprint that could accelerate development of sustainable, lab-based cannabinoid production, enabling more consistent and scalable manufacturing of cannabis-derived medicines and products without relying on plant cultivation or energy-intensive synthesis.